These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
93 related items for PubMed ID: 9851395
21. [Treatment with botulinum toxin in blepharospasm]. Grandas F. Arch Neurobiol (Madr); 1991; 54(5):206-9. PubMed ID: 1804034 [Abstract] [Full Text] [Related]
22. [Treatment with botulinum toxin in blepharospasm]. Grandas F. Arch Neurobiol (Madr); 1991; 54 Suppl 3():40-3. PubMed ID: 1810207 [Abstract] [Full Text] [Related]
23. Frontalis suspension for essential blepharospasm unresponsive to botulinum toxin therapy. First results. Roggenkämper P, Nüssgens Z. Ger J Ophthalmol; 1993 Nov; 2(6):426-8. PubMed ID: 8312829 [Abstract] [Full Text] [Related]
24. Predictors of postoperative myasthenic crisis in patients with myasthenia gravis after thymectomy. Chu XY, Xue ZQ, Wang RW, Tan QY. Chin Med J (Engl); 2011 Apr; 124(8):1246-50. PubMed ID: 21543005 [Abstract] [Full Text] [Related]
25. Variable ptosis after botulinum toxin type a injection with positive ice test mimicking ocular myasthenia gravis. Alaraj AM, Oystreck DT, Bosley TM. J Neuroophthalmol; 2013 Jun; 33(2):169-71. PubMed ID: 23681240 [Abstract] [Full Text] [Related]
26. Botulinum toxin A in blepharospasm and hemifacial spasm. Behari M, Singh KK, Seshadri S, Prasad K, Ahuja GK. J Assoc Physicians India; 1994 Mar; 42(3):205-8. PubMed ID: 7860509 [Abstract] [Full Text] [Related]
27. [Treatment of facial spasm using botulinum toxin]. Ruusuvaara P, Setälä K. Duodecim; 1991 Mar; 107(19):1627-9. PubMed ID: 1365929 [No Abstract] [Full Text] [Related]
31. Botulinum toxin for spasmodic torticollis in a patient with myasthenia gravis. Emmerson J. Mov Disord; 1994 May; 9(3):367. PubMed ID: 8041381 [No Abstract] [Full Text] [Related]
32. A new botulinum toxin (Xeomin) for cervical dystonia and blepharospasm. Med Lett Drugs Ther; 2010 Nov 15; 52(1351):90-1. PubMed ID: 21068703 [Abstract] [Full Text] [Related]
34. Botulinum toxin for the treatment of essential blepharospasm. Shore JW, Leone CR, O'Connor PS, Neuhaus RW, Arnold AC. Ophthalmic Surg; 1986 Nov 15; 17(11):747-53. PubMed ID: 3808585 [Abstract] [Full Text] [Related]
35. A comparative study of tear secretion in blepharospasm and hemifacial spasm patients treated with botulinum toxin. Price J, O'Day J. J Clin Neuroophthalmol; 1993 Mar 15; 13(1):67-71. PubMed ID: 8501266 [Abstract] [Full Text] [Related]
36. Myasthenia gravis: management of myasthenic crisis and perioperative care. Juel VC. Semin Neurol; 2004 Mar 15; 24(1):75-81. PubMed ID: 15229794 [Abstract] [Full Text] [Related]
37. Local side effects of botulinum toxin injections. Patrinely JR, Whiting AS, Anderson RL. Adv Neurol; 1988 Mar 15; 49():493-500. PubMed ID: 3278553 [No Abstract] [Full Text] [Related]
38. [Clinical and therapeutic aspects of essential blepharospasm]. Russegger L, Grunert V. Nervenarzt; 1989 Jul 15; 60(7):401-6. PubMed ID: 2761660 [Abstract] [Full Text] [Related]
39. [Botulinum toxin A in therapy of craniocervical dystonias and hemifacial spasm]. Thill R, Költringer P, Reisecker F, Maller J, Leblhuber F. Acta Med Austriaca; 1991 Jul 15; 18(5):125-9. PubMed ID: 1796725 [Abstract] [Full Text] [Related]
40. Botulinum toxin injection for ocular muscle disorders. Med Lett Drugs Ther; 1987 Nov 06; 29(752):101-2. PubMed ID: 3670214 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]